Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : PJ November 2015 online

Sort by: Newest first Oldest first A-Z Z-A

  • Under the terms agreed for the World Trade Organization (WTO) (Geneva headquarters pictured) health programs in poor countries won't need to protect drug patents until 1 January 2033

    World’s poorest countries don’t need to protect drug patents until 2033, agrees WTO Subscription

    9 NOV 2015 14:25 By John Zarocostas

    The world’s poorest countries have been given an extension of 17 years to a waiver exempting them from implementing rules protecting drug patents and undisclosed clinical test data, the World Trade Organization (WTO) agreed on 6 November 2015.

  • Pharmacist Rob Morris (pictured) has spent his career developing and selling medicines for farm animals and pets. He encourages other pharmacists to consider the sector, even though jobs may be scarce.

    Why I chose veterinary pharmacy instead of community or hospital Subscription

    30 NOV 2015 16:16 By Rob Morris

    Practising veterinary pharmacy offers flexibility and creativity that the traditional sectors do not, writes Rob Morris.

  • Patients with subarachnoid haemorrhage (SAH) developing stress-induced cardiomyopathy (SIC), coloured x-ray pictured. Research found that these patients had higher peak levels of the cardiac damage peptides hsTnT and NTproBNP

    Two peptides predict cardiomyopathy after brain haemorrhage Subscription

    3 DEC 2015 11:06

    Swedish PhD student finds biomarkers that can identify subarachnoid haemorrhage patients at risk of cardiomyopathy.

  • Researchers say findings add further evidence supporting the cardiovascular safety of testosterone supplementation in this group of patients. In the image, light micrograph of testosterone hormone

    Study supports cardiovascular safety of testosterone Subscription

    25 NOV 2015 11:09

    Despite FDA warnings, no link found between testosterone therapy and cardiovascular risks.

  • Side effects with Eviplera Subscription

    27 NOV 2015 14:30

    The summary of product characteristics for Eviplera (emtricitabine, rilpivirine, tenofovir disoproxil; Gilead) now states that Eviplera must be discontinued as soon as serious skin and/or mucosal reactions are observed, and appropriate therapy should be initiated. 

  • Sexual health learning programme Subscription

    13 NOV 2015 10:11

    The Centre for Pharmacy Postgraduate Education (CPPE) has launched a new e-learning module called ‘Sexual health in pharmacies’. It is designed to help pharmacists and their teams deliver sexual health services. This programme replaces the ‘Sexual health in pharmacies: developing your service’ distance learning programme. The new programme can be accessed via ...

  • Reyataz boosted regimen Subscription

    13 NOV 2015 8:58

    Ordinarily, treatment of HIV-1 with Reyataz (atazanavir; Bristol Myers Squibb) is boosted by co-administration with ritonavir. However, the summary of product characteristics has been updated to reflect that, under certain circumstances, ritonavir does not need to be co-administered, for example in patients with hepatic impairment. 

  • Resource for pharmacists affected by migrant crisis Subscription

    27 NOV 2015 14:12

    The International Pharmaceutical Federation (FIP) has published new guidance to help pharmacists affected by the current migrant crisis in Europe. The guidance links pharmacists who may be struggling to communicate with these individuals to useful resources. It is available from the FIP website.

  • A strain of Escherichia coli (micrograph pictured) in the guts of mice appears to protect them from muscle wasting associated with infection and inflammatory bowel disease, research finds

    Researchers identify E. coli strain that protects against ‘collateral damage’ of infections Subscription

    2 NOV 2015 16:29 By Janna Lawrence

    A strain of Escherichia coli in the guts of mice appears to protect them from muscle wasting associated with infection and inflammatory bowel disease, according to research published in Science.

  • Relpax back in stock Subscription

    13 NOV 2015 14:50

    Relpax (eletriptan hydrobromide) film-coated tablets 40mg are now back in stock from Pfizer.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.